Well Lead Med Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 4.40%

Well Lead Med Co Ltd (603309) has an Asset Resilience Ratio of 4.40% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Explore investment intensity of Well Lead Med Co Ltd to see how much of total assets are deployed in long-term investments.

Liquid Assets

CN¥128.05 Million
≈ $18.74 Million USD Cash + Short-term Investments

Total Assets

CN¥2.91 Billion
≈ $425.49 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Well Lead Med Co Ltd's Asset Resilience Ratio has changed over time. See Well Lead Med Co Ltd (603309) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets Composition Over Time

This chart breaks down Well Lead Med Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Well Lead Med Co Ltd (603309) total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥128.05 Million 4.4%
Total Liquid Assets CN¥128.05 Million 4.40%

Asset Resilience Insights

  • Limited Liquidity: Well Lead Med Co Ltd maintains only 4.40% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Well Lead Med Co Ltd Industry Peers by Asset Resilience Ratio

Compare Well Lead Med Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
Medical Instruments & Supplies 9.87%
Kyobo 8 Special Purpose Acquisition Company
KQ:307280
Medical Instruments & Supplies 9.73%
Safe Orthopaedics SA
PA:ALSAF
Medical Instruments & Supplies 2.20%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 7.53%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 46.84%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 3.36%
Austco Healthcare Ltd
AU:AHC
Medical Instruments & Supplies 15.90%
Trajan Group Holdings Ltd
AU:TRJ
Medical Instruments & Supplies 0.29%

Annual Asset Resilience Ratio for Well Lead Med Co Ltd (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Well Lead Med Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 6.78% CN¥192.62 Million
≈ $28.19 Million
CN¥2.84 Billion
≈ $415.68 Million
+1.25pp
2023-12-31 5.53% CN¥144.08 Million
≈ $21.08 Million
CN¥2.61 Billion
≈ $381.23 Million
-7.51pp
2022-12-31 13.04% CN¥310.94 Million
≈ $45.50 Million
CN¥2.38 Billion
≈ $348.80 Million
+11.63pp
2021-12-31 1.42% CN¥30.19 Million
≈ $4.42 Million
CN¥2.13 Billion
≈ $312.03 Million
+0.00pp
2018-12-31 1.41% CN¥20.00 Million
≈ $2.93 Million
CN¥1.41 Billion
≈ $206.98 Million
-25.18pp
2017-12-31 26.60% CN¥268.81 Million
≈ $39.34 Million
CN¥1.01 Billion
≈ $147.90 Million
-7.95pp
2016-12-31 34.54% CN¥336.00 Million
≈ $49.17 Million
CN¥972.68 Million
≈ $142.33 Million
-2.57pp
2015-12-31 37.11% CN¥327.00 Million
≈ $47.85 Million
CN¥881.08 Million
≈ $128.93 Million
--
pp = percentage points

About Well Lead Med Co Ltd

SHG:603309 China Medical Instruments & Supplies
Market Cap
$504.83 Million
CN¥3.45 Billion CNY
Market Cap Rank
#12220 Global
#3545 in China
Share Price
CN¥11.82
Change (1 day)
+1.98%
52-Week Range
CN¥11.06 - CN¥15.95
All Time High
CN¥33.54
About

Well Lead Medical Co., Ltd. engages in the development, production, and sale of medical devices in urology, endourology, anaesthesia, respiratory, hemodialysis, and pain management areas worldwide. It provides urology products, including Foley catheter, Nelaton catheters, urine collection products, and accessories; endourology products, such as the ClearPetra family system, ureterorenoscope, guid… Read more